A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?

Applied Health Economics and Health Policy

Volumn 13, Issue , 2015, Pages 35-45

  Toverud, Else Lydia ^a   Hartmann, Katrin ^b   Håkonsen, Helle ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

BIOEQUIVALENCE; COST CONTROL; DRUG CONTROL; DRUG USE; HEALTH CARE SYSTEM; HOSPITAL POLICY; HUMAN; PATIENT EDUCATION; PERCEPTION; PHARMACIST; PHARMACIST ATTITUDE; PHYSICIAN; PHYSICIAN ATTITUDE; PRESCRIPTION; REVIEW; SOCIAL STATUS; SYSTEMATIC REVIEW; CULTURAL FACTOR; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG SUBSTITUTION; ECONOMICS; HEALTH PERSONNEL ATTITUDE; INTERNATIONAL COOPERATION; PROCEDURES; QUALITY CONTROL; QUESTIONNAIRE; STANDARDS; THERAPEUTIC EQUIVALENCE;

ATTITUDE OF HEALTH PERSONNEL; COST CONTROL; CROSS-CULTURAL COMPARISON; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DRUG SUBSTITUTION; DRUGS, GENERIC; HUMANS; INTERNATIONALITY; PHARMACISTS; PHYSICIANS; QUALITY CONTROL; SURVEYS AND QUESTIONNAIRES; THERAPEUTIC EQUIVALENCY;

EID: 84938416610     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-014-0145-2     Document Type: Review

References (35)

1. Håkonsen H, Horn AM, Toverud EL. Price control as a strategy for pharmaceutical cost containment—what has been achieved in Norway in the period 1994–2004? Health Policy. 2009;90(2–3):277–85.
2. Håkonsen H, Toverud EL. A review of patient perspectives on generic substitution: what are the challenges for optimal drug use? GaBI J. 2012;1(1):28–32.
3. Ojikutu B, Jack C, Ramjee G. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles. J Infect Dis. 2007;196(Suppl 3):S523–7.
4. Nakai K, Fujita M, Ogata H. International harmonization of bioequivalence studies and issues shared in common. Yakugaku Zasshi. 2000;120(11):1193–200.
5. Håkonsen H, Eilertsen M, Borge H, Toverud EL. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin. 2009;25(10):2515–21.
6. Håkonsen H, Hopen HS, Abelsen L, Ek B, Toverud EL. Generic substitution: a potential risk factor for medication errors in hospitals. Adv Ther. 2010;27(2):118–26.
7. Håkonsen H, Toverud EL. Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway. Eur J Clin Pharmacol. 2011;67(2):193–201.
8. Danish Health and Medicines Authority. Rapport om generisk ordination—fordele og ulemper. Denmark: Lægemiddelstyrelsen; 2006 [In Danish]. https://sundhedsstyrelsen.dk/da/udgivelser/2006/rapport-om-generisk-ordination-fordele-og-ulemper. Accessed 21 Nov 2014.
9. Bearden WO, Mason JB. Consumer-perceived risk and attitudes toward generically prescribed drugs. J Appl Psychol. 1978;63(6):741–6.
10. Nelson AA, Gagnon JP. Brand substitution the consumer’s viewpoint. J Am Pharm Assoc. 1975;15(7):382–5 (91).
11. Toverud EL, Røise AK, Hogstad G, Wabø I. Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences. Eur J Clin Pharmacol. 2011;67(1):33–8.
12. Paraponaris A, Verger P, Desquins B, Villani P, Bouvenot G, Rochaix L, Gourheux JC, Moatti JP, Panel MG Paca. Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Health Policy. 2004;70(1):23–32.
13. Kersnik J, Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. J Clin Pharm Ther. 2006;31(6):577–83.
14. de Run CE, Felix MKN. Patented and generic pharmaceutical drugs: perception and prescription. Inter J Bus Soc. 2006;7(2):55–78.
15. Hassali MA, Kong DCM, Stewart K. Generic medicines: perceptions of general practitioners in Melbourne, Australia. J Generic Med. 2006;3(3):214–25.
16. Gossell-Williams M. Generic substitutions: a 2005 survey of the acceptance and perceptions of physicians in Jamaica. West Indian Med J. 2007;56(5):458–63.
17. Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74.
18. Polinski JM, Maclure M, Marshall B, Cassels A, Agnew-Blais J, Patrick AR, Schneeweiss S. Does knowledge of medication prices predict physicians’ support for cost effective prescribing policies. Can J Clin Pharmacol. 2008;15(2):e286–94.
19. Alghasham AA. Generic drug prescribing in central Saudi Arabia: perceptions and attitudes of physicians. Ann Saudi Med. 2009;29(1):24–9.
20. Tsiantou V, Zavras D, Kousoulakou H, Geitona M, Kyriopoulos J. Generic medicines: Greek physicians’ perceptions and prescribing practices. J Clin Pharm Ther. 2009;34(5):547–54.
21. Theodorou M, Tsiantou V, Pavlakis A, Maniadakis N, Fragoulakis V, Pavi E, Kyriopoulos J. Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey. BMC Health Serv Res. 2009;9:150.
22. Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy. 2010;95(2–3):229–35.
23. Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, Choudhry NK. Physician perceptions about generic drugs. Ann Pharmacother. 2011;45(1):31–8.
24. Jamshed SQ, Hassali MA, Ibrahim MI, Babar ZU. Knowledge attitude and perception of dispensing doctors regarding generic medicines in Karachi, Pakistan: a qualitative study. J Pak Med Assoc. 2011;61(1):80–3.
25. Jamshed SQ, Ibrahim MI, Hassali MA, Masood I, Low BY, Shafie AA, Babar ZU. Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: a questionnaire based study. South Med Rev. 2012;5(1):22–30.
26. Fabiano V, Mameli C, Cattaneo D, Delle Fave A, Preziosa A, Mele G, Clementi E, Zuccotti GV. Perceptions and patterns of use of generic drugs among Italian family pediatricians: first round results of a web survey. Health Policy. 2012;104(3):247–52.
27. Skinstad S. Norwegian general practitioners’ experiences with and attitudes towards generic substitution in pharmacies. Master thesis. University of Oslo; 2012.
28. Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharm World Sci. 2003;25(5):197–202.
29. Babar ZU, Awaisu A. Evaluating community pharmacists’ perceptions and practices on generic medicines: a pilot study from Peninsular Malaysia. J Generic Med. 2008;5:315–30.
30. Gill L, Helkkula A, Cobelli N, White L. How do customers and pharmacists experience generic substitution? Inter J Pharm Healthcare Mark. 2010;4(4):375–95.
31. Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48.
32. Babar ZU, Grover P, Stewart J, Hogg M, Short L, Seo HG, Rew A. Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand. Res Social Adm Pharm. 2011;7(3):294–305.
33. Chong CP, Hassali MA, Bahari MB, Shafie AA. Exploring community pharmacists’ views on generic medicines: a nationwide study from Malaysia. Int J Clin Pharm. 2011;33(1):124–31.
34. Olsson E, Kälvemark Sporrong S. Pharmacists’ experiences and attitudes regarding generic drugs and generic substitution: two sides of the coin. Int J Pharm Pract. 2012;20(6):377–83.
35. Basak SC, Sathyanarayana D. Exploring knowledge and perceptions of generic medicines among drug retailers and community pharmacists. Indian J Pharm Sci. 2012;74(6):571–5.